Use of a high-throughput screen of primary leukemia cells to personalize therapy for relapsed/refractory AML: Proof of concept and clinical implementation of precision medicine.

被引：0
|
作者：
Shum, David [1 ]
Heaney, Mark [2 ]
Brentjens, Renier [1 ]
Maslak, Peter [1 ]
Jurcic, Joseph [2 ]
Djaballah, Hakim [1 ]
Frattini, Mark G. [2 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] Columbia Univ, Med Ctr, New York, NY USA
来源：
CLINICAL CANCER RESEARCH | 2015年 / 21卷
关键词：
D O I：
10.1158/1557-3265.HEMMAL14-A28
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A28
引用
收藏
页数：2
相关论文
共 4 条
  • [1] A novel high-throughput screen of primary leukemia cells to personalize therapy for relapsed/refractory acute myeloid leukemia (AML): Proof of concept and clinical implementation of precision medicine
    Shum, David
    Santos, Ruth
    Heaney, Mark
    Brentjens, Renier
    Maslak, Peter
    Rosenblat, Todd
    Jurcic, Joseph
    Djaballah, Hakim
    Frattini, Mark G.
    CLINICAL CANCER RESEARCH, 2015, 21
  • [2] CLINICAL IMPLEMENTATION OF A NOVEL HIGH-THROUGHPUT SCREEN OF PRIMARY LEUKEMIA CELLS TO PERSONALIZE THERAPY FOR RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (AML)
    Frattini, M.
    Shum, D.
    Heaney, M.
    Brentjens, R.
    Maslak, P.
    Jurcic, J.
    Djaballah, H.
    HAEMATOLOGICA, 2012, 97 : 19 - 19
  • [3] Clinical Implementation of a Novel High-Throughput Screen of Primary Leukemia Cells to Customize Therapy for Relapsed/Refractory Acute Myeloid Leukemia (AML).
    O'Dwyer, Kristen M.
    Shum, David
    Heaney, Mark
    Brentjens, Renier J.
    Maslak, Peter
    Jurcic, Joseph G.
    Djaballah, Hakim
    Frattini, Mark G.
    BLOOD, 2009, 114 (22) : 1042 - 1042
  • [4] Functional Precision Medicine in AML: Technical Performance Evaluation for in Vitro Diagnostics Using High-Throughput Image-Based Screening of Primary Patient Cells
    Krall, Nikolaus
    Meszaros, Noemi
    Lind, Karin
    Vilagos, Bojan
    Sill, Heinz
    Vladimer, Gregory Ian
    BLOOD, 2019, 134
1